Janssen is one of the world’s leading research-based pharmaceutical organisations and is part of the Johnson & Johnson family of companies, the largest diversified healthcare group in the world with over 100 years of scientific heritage. We have access to a global pool of resources and talent which allows us to continue our pioneering work in discovering innovative medicines to improve patients’ lives and to follow in the footsteps of our founder Dr. Paul Janssen who famously said, "patients are waiting".
Packie Bonner launches new support book for men living with prostate cancer entitled Man to Man: Irish Stories of Hope in Prostate Cancer (Dublin, 30th May 2014): A new and inspiring prostate cancer patient storybook resource for men experiencing..
New study shows gay and bisexual men in Ireland consider it unlikely that they will contract HIV Dublin, Wed, 4th June 2014: Ahead of Irish AIDS Day on the 15th of June, Janssen in partnership with the Gay Health Network has..
New research carried out during Movember among family members of those living with prostate cancer today reveals the impact of chemotherapy on patients ahead of World Cancer Day (Feb 4th). The study supported by Janssen shows chemotherapy brought major changes in..
Johnson & Johnson has announced that the Company, through its subsidiary Janssen Research and Development, LLC, has entered into a novel agreement with Yale School of Medicine’s Open Data Access (YODA) Project to extend its commitment to sharing clinical trials..